Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION
Report ID | 183741 |
Drug Identification Number | 02423227 |
Brand name | AMIODARONE HYDROCHLORIDE FOR INJECTION |
Common or Proper name | Amiodarone Hydrochloride |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | AMIODARONE HYDROCHLORIDE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 3 mL vials |
ATC code | C01BD |
ATC description | ANTIARRHYTHMICS, CLASS I AND III |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-05-15 |
Actual start date | |
Estimated end date | 2023-06-15 |
Actual end date | 2023-03-07 |
Shortage status | Avoided shortage |
Updated date | 2023-03-11 |
Company comments | Under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2023-03-11 | French | Compare |
v10 | 2023-03-11 | English | Compare |
v9 | 2023-02-11 | French | Compare |
v8 | 2023-02-11 | English | Compare |
v7 | 2023-02-10 | French | Compare |
v6 | 2023-02-10 | English | Compare |
v5 | 2023-02-08 | French | Compare |
v4 | 2023-02-08 | English | Compare |
v3 | 2023-02-07 | English | Compare |
v2 | 2023-02-06 | French | Compare |
v1 | 2023-02-06 | English | Compare |
Showing 1 to 11 of 11